ACER THERAPEUTICS INC. Earnings Per Share (Diluted)
ACER THERAPEUTICS INC. reported Earnings Per Share (Diluted) of -$0.60 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2023-11-20
- ACER THERAPEUTICS INC. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.60.
- ACER THERAPEUTICS INC. earnings per share, diluted for the quarter ending 2023-06-30 was -$0.33.
- ACER THERAPEUTICS INC. earnings per share, diluted for the quarter ending 2023-03-31 was -$0.77.
- ACER THERAPEUTICS INC. earnings per share, diluted for the quarter ending 2022-09-30 was -$0.31.
- ACER THERAPEUTICS INC. earnings per share, diluted for fiscal 2022 was -$1.66.
- ACER THERAPEUTICS INC. earnings per share, diluted for fiscal 2021 was -$1.08.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | -$0.60 10-Q · filed 2023-11-20 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-20 | -$1.68 10-Q · filed 2023-11-20 | ||
| 2023-06-30 | -$0.33 10-Q · filed 2023-08-14 | -$1.07 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | -$0.77 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | -$1.66 10-K · filed 2023-03-27 | ||||
| 2022-09-30 | -$0.31 10-Q · filed 2023-11-20 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-11-20 | -$1.13 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | -$0.30 10-Q · filed 2023-08-14 | -$0.64 10-Q · filed 2022-08-15 | -$0.83 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.64 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | -$1.08 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | -$0.23 10-Q · filed 2022-11-14 | -$0.77 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$0.21 10-Q/A · filed 2022-11-14 | -$0.54 10-Q/A · filed 2022-11-14 |